Santhera Pharmaceuticals
SANN.SW
#8533
Rank
C$0.20 B
Marketcap
$16.84
Share price
4.81%
Change (1 day)
8.07%
Change (1 year)

Revenue for Santhera Pharmaceuticals (SANN.SW)

Revenue in 2018 (TTM): C$36.67 Million

According to Santhera Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$40.71 Million. In 2023 the company made a revenue of C$0.17 Billion an increase over the revenue in the year 2022 that were of C$11.61 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Santhera Pharmaceuticals from 2006 to 2018

Annual revenue

Year Revenue Change
2023C$0.17 B1420.52%
2022C$11.61 M-563.4%
2021-C$2.51 Million-110.25%
2020C$24.44 M-78.12%
2019C$0.11 B141.78%
2018 C$46.21 M36.6%
2017 C$33.83 M26.11%
2016C$26.82 M327.21%
2015C$6.27 M66.86%
2014C$3.76 M76.3%
2013C$2.13 M-61.65%
2012C$5.56 M11.39%
2011C$4.99 M-84.22%
2010C$31.66 M2.1%
2009C$31.01 M46831.09%
2008C$0.06 M
2007N/A-100%
2006C$0.92 M